Copyright Reports & Markets. All rights reserved.

Global Artificial Heart and Ventricular Assist Devices Market Research Report 2021

Request for Sample of this report
Buy now

1 Artificial Heart and Ventricular Assist Devices Market Overview

  • 1.1 Product Overview and Scope of Artificial Heart and Ventricular Assist Devices
  • 1.2 Artificial Heart and Ventricular Assist Devices Segment by Type
    • 1.2.1 Global Artificial Heart and Ventricular Assist Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Artificial Heart
    • 1.2.3 Ventricular Assist Devices
  • 1.3 Artificial Heart and Ventricular Assist Devices Segment by Application
    • 1.3.1 Artificial Heart and Ventricular Assist Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Coronary Heart Disease
    • 1.3.3 Cerebrovascular Disease
    • 1.3.4 Peripheral Arterial Disease
    • 1.3.5 Rheumatic Heart Disease
    • 1.3.6 Congenital Heart Disease
    • 1.3.7 Deep Vein Thrombosis
    • 1.3.8 Other
  • 1.4 Global Artificial Heart and Ventricular Assist Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Artificial Heart and Ventricular Assist Devices Revenue 2016-2027
    • 1.4.2 Global Artificial Heart and Ventricular Assist Devices Sales 2016-2027
    • 1.4.3 Artificial Heart and Ventricular Assist Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Heart and Ventricular Assist Devices Market Competition by Manufacturers

  • 2.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Artificial Heart and Ventricular Assist Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Artificial Heart and Ventricular Assist Devices Market Competitive Situation and Trends
    • 2.5.1 Artificial Heart and Ventricular Assist Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Artificial Heart and Ventricular Assist Devices Players Market Share by Revenue
    • 2.5.3 Global Artificial Heart and Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario by Region

  • 3.1 Global Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
    • 3.3.1 North America Artificial Heart and Ventricular Assist Devices Sales by Country
    • 3.3.2 North America Artificial Heart and Ventricular Assist Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
    • 3.4.1 Europe Artificial Heart and Ventricular Assist Devices Sales by Country
    • 3.4.2 Europe Artificial Heart and Ventricular Assist Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Region
    • 3.5.2 Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Artificial Heart and Ventricular Assist Devices Sales by Country
    • 3.6.2 Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Artificial Heart and Ventricular Assist Devices Sales by Country
    • 3.7.2 Middle East and Africa Artificial Heart and Ventricular Assist Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Artificial Heart and Ventricular Assist Devices Historic Market Analysis by Type

  • 4.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Artificial Heart and Ventricular Assist Devices Price by Type (2016-2021)

5 Global Artificial Heart and Ventricular Assist Devices Historic Market Analysis by Application

  • 5.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Artificial Heart and Ventricular Assist Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 SynCardia Systems
    • 6.1.1 SynCardia Systems Corporation Information
    • 6.1.2 SynCardia Systems Description and Business Overview
    • 6.1.3 SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 SynCardia Systems Product Portfolio
    • 6.1.5 SynCardia Systems Recent Developments/Updates
  • 6.2 Medtronic PLC
    • 6.2.1 Medtronic PLC Corporation Information
    • 6.2.2 Medtronic PLC Description and Business Overview
    • 6.2.3 Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Medtronic PLC Product Portfolio
    • 6.2.5 Medtronic PLC Recent Developments/Updates
  • 6.3 Abbott Laboratories
    • 6.3.1 Abbott Laboratories Corporation Information
    • 6.3.2 Abbott Laboratories Description and Business Overview
    • 6.3.3 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Abbott Laboratories Product Portfolio
    • 6.3.5 Abbott Laboratories Recent Developments/Updates
  • 6.4 BiVACOR
    • 6.4.1 BiVACOR Corporation Information
    • 6.4.2 BiVACOR Description and Business Overview
    • 6.4.3 BiVACOR Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BiVACOR Product Portfolio
    • 6.4.5 BiVACOR Recent Developments/Updates
  • 6.5 Berlin Heart
    • 6.5.1 Berlin Heart Corporation Information
    • 6.5.2 Berlin Heart Description and Business Overview
    • 6.5.3 Berlin Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Berlin Heart Product Portfolio
    • 6.5.5 Berlin Heart Recent Developments/Updates
  • 6.6 ABIOMED
    • 6.6.1 ABIOMED Corporation Information
    • 6.6.2 ABIOMED Description and Business Overview
    • 6.6.3 ABIOMED Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 ABIOMED Product Portfolio
    • 6.6.5 ABIOMED Recent Developments/Updates
  • 6.7 LivaNova PLC
    • 6.6.1 LivaNova PLC Corporation Information
    • 6.6.2 LivaNova PLC Description and Business Overview
    • 6.6.3 LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 LivaNova PLC Product Portfolio
    • 6.7.5 LivaNova PLC Recent Developments/Updates
  • 6.8 CARMAT
    • 6.8.1 CARMAT Corporation Information
    • 6.8.2 CARMAT Description and Business Overview
    • 6.8.3 CARMAT Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 CARMAT Product Portfolio
    • 6.8.5 CARMAT Recent Developments/Updates
  • 6.9 Jarvik Heart Inc
    • 6.9.1 Jarvik Heart Inc Corporation Information
    • 6.9.2 Jarvik Heart Inc Description and Business Overview
    • 6.9.3 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Jarvik Heart Inc Product Portfolio
    • 6.9.5 Jarvik Heart Inc Recent Developments/Updates
  • 6.10 Chongqing Yongrenxin Medical
    • 6.10.1 Chongqing Yongrenxin Medical Corporation Information
    • 6.10.2 Chongqing Yongrenxin Medical Description and Business Overview
    • 6.10.3 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Chongqing Yongrenxin Medical Product Portfolio
    • 6.10.5 Chongqing Yongrenxin Medical Recent Developments/Updates
  • 6.11 Thoratec
    • 6.11.1 Thoratec Corporation Information
    • 6.11.2 Thoratec Artificial Heart and Ventricular Assist Devices Description and Business Overview
    • 6.11.3 Thoratec Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Thoratec Product Portfolio
    • 6.11.5 Thoratec Recent Developments/Updates
  • 6.12 Cleveland Heart
    • 6.12.1 Cleveland Heart Corporation Information
    • 6.12.2 Cleveland Heart Artificial Heart and Ventricular Assist Devices Description and Business Overview
    • 6.12.3 Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Cleveland Heart Product Portfolio
    • 6.12.5 Cleveland Heart Recent Developments/Updates
  • 6.13 CryoLife
    • 6.13.1 CryoLife Corporation Information
    • 6.13.2 CryoLife Artificial Heart and Ventricular Assist Devices Description and Business Overview
    • 6.13.3 CryoLife Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 CryoLife Product Portfolio
    • 6.13.5 CryoLife Recent Developments/Updates

7 Artificial Heart and Ventricular Assist Devices Manufacturing Cost Analysis

  • 7.1 Artificial Heart and Ventricular Assist Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Artificial Heart and Ventricular Assist Devices
  • 7.4 Artificial Heart and Ventricular Assist Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Artificial Heart and Ventricular Assist Devices Distributors List
  • 8.3 Artificial Heart and Ventricular Assist Devices Customers

9 Artificial Heart and Ventricular Assist Devices Market Dynamics

  • 9.1 Artificial Heart and Ventricular Assist Devices Industry Trends
  • 9.2 Artificial Heart and Ventricular Assist Devices Growth Drivers
  • 9.3 Artificial Heart and Ventricular Assist Devices Market Challenges
  • 9.4 Artificial Heart and Ventricular Assist Devices Market Restraints

10 Global Market Forecast

  • 10.1 Artificial Heart and Ventricular Assist Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Artificial Heart and Ventricular Assist Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Artificial Heart and Ventricular Assist Devices by Type (2022-2027)
  • 10.2 Artificial Heart and Ventricular Assist Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Artificial Heart and Ventricular Assist Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Artificial Heart and Ventricular Assist Devices by Application (2022-2027)
  • 10.3 Artificial Heart and Ventricular Assist Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Artificial Heart and Ventricular Assist Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Artificial Heart and Ventricular Assist Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Artificial Heart
    Ventricular Assist Devices

    Segment by Application
    Coronary Heart Disease
    Cerebrovascular Disease
    Peripheral Arterial Disease
    Rheumatic Heart Disease
    Congenital Heart Disease
    Deep Vein Thrombosis
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    SynCardia Systems
    Medtronic PLC
    Abbott Laboratories
    BiVACOR
    Berlin Heart
    ABIOMED
    LivaNova PLC
    CARMAT
    Jarvik Heart Inc
    Chongqing Yongrenxin Medical
    Thoratec
    Cleveland Heart
    CryoLife

    Buy now